The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Adverum Biotechnologies, Inc. | Common Stock | 00773U108 | 8,058,490 | 5,068,233 | SH | OTR | 0 | 5,068,233 | 0 | |||
Aligos Therapeutics, Inc. | Common Stock | 01626L105 | 2,253,090 | 2,320,381 | SH | OTR | 0 | 2,320,381 | 0 | |||
CRISPR Therapeutics AG | Common Shares | H17182108 | 27,989,046 | 498,558 | SH | OTR | 0 | 498,558 | 0 | |||
CymaBay Therapeutics, Inc. | Common Stock | 23257D103 | 5,954,095 | 543,753 | SH | OTR | 0 | 543,753 | 0 | |||
Gritstone Oncology, Inc. | Common Stock | 39868T105 | 6,944,243 | 3,561,150 | SH | OTR | 0 | 3,561,150 | 0 | |||
Passage Bio, Inc. | Common Stock | 702712100 | 4,668,631 | 4,959,769 | SH | OTR | 0 | 4,959,769 | 0 | |||
Repare Therapeutics, Inc. | Common Stock | 760273102 | 28,001,631 | 2,646,657 | SH | OTR | 0 | 2,646,657 | 0 | |||
Minerva Surgical Inc. | Common Stock | 60343F106 | 428,802 | 1,673,700 | SH | OTR | 0 | 1,673,700 | 0 |